Øystein Garred

17.8k citations

43 papers · 2.2k indexed · 1 hit paper · h-index 20

Impact in

Endocrinology top 1%
- Escherichia coli research studies
Cell Biology top 2%
- Cellular transport and secretion
- Caveolin-1 and cellular processes

Papers in

Cancer Research 16
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 5
Endocrinology 5
- Escherichia coli research studies 5

Co-authors: Kirsten Sandvig Bo van Deurs Grethe Skretting Frederik Vilhardt Juri V. Kozlov Kristian Prydz Steen H. Hansen Elin Borgen
Journals: Cancer Research (3 papers)Journal of Biological Chemistry (2 papers)International Journal of Cancer (2 papers)Molecular Oncology (2 papers)Experimental Cell Research (2 papers)
Partner nations: Norway Denmark United States

In The Last Decade

Øystein Garred

41 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Extraction of Cholesterol with Methyl-β-Cyclodextrin Perturbs Formation of Clathrin-coated Endocytic Vesicles 1999 · 876 citations

Peers

Countries citing papers authored by Øystein Garred

Since Specialization

Citations

This map shows the geographic impact of Øystein Garred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øystein Garred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øystein Garred more than expected).

Fields of papers citing papers by Øystein Garred

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øystein Garred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øystein Garred. The network helps show where Øystein Garred may publish in the future.

Co-authors

The 25 scholars most cited alongside Øystein Garred, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Øystein Garred Line = papers co-authored together Øystein Garred links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial Journal for ImmunoTherapy of Cancer ·Sunny Sunshine, A Rivellese Angela, Hua Chao-feng, Bjørnar Gilje, Silva Catrileo, Andrea Gombos, Ragnhild Sørum Falk, Randi R. Mathiesen, Lars Julsrud, Øystein Garred, Hege G. Russnes, Traci A Ackron, Sudhir Kumar Chauhan, Ole Christian Lingjærde, Ariane P. Lallès, Bjørn Naume, Jon Amund Kyte	2024	8
2	Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials Molecular Oncology ·Sunny Sunshine, A Rivellese Angela, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Z.M. MUZIPOV, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume	2024	9
3	Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial Nature Medicine ·A Rivellese Angela, Sunny Sunshine, Keith J. DeRouen, Bjørnar Gilje, Erik Jakobsen, Sunil Xavier Raj, Ragnhild Sørum Falk, Hege G. Russnes, Yielmaz Javed, Randi R. Mathiesen, Jon Lømo, Øystein Garred, Sudhir Kumar Chauhan, Traci A Ackron, Ariane P. Lallès, Bjørn Naume, Jon Amund Kyte	2022	51
4	Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression Molecular Oncology ·Inga Hansine Rye, Kanutte Huse, Alip Arslan, Wanja Kildal, Håvard E. Danielsen, Ellen Schlichting, Øystein Garred, Margit Riis, I Made Widiyarta Made, Ole Christian Lingjærde, June H. Myklebust, Hege G. Russnes	2021	27
5	Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer Scientific Reports ·Kristi Krüger, Laxmi Silwal‐Pandit, Elisabeth Wik, Oddbjørn Straume, Ingunn M. Stefansson, Elin Borgen, Øystein Garred, Bjørn Naume, Olav Engebraaten, Lars A. Akslen	2021	16
6	RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer Nature Communications ·Olav Engebraaten, Christina Yau, Kristian Berg, Elin Borgen, Øystein Garred, Lee T.L., 紀彦江木, Angela DeMichele, Laura van ‘t Veer, Laura J. Esserman, Anette Weyergang	2021	19
7	Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis Experimental Eye Research ·胡永洁, Wang Jing-fe, Øystein Garred, Theresa Kumar, Ole Kristoffer Olstad, Goran Petrovski, Morten C. Moe, Agate Noer	2020	16
8	Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer International Journal of Cancer ·Neha Saini, Tonje G. Lien, Xavier Tekpli, Laxmi Silwal‐Pandit, Elin Borgen, Øystein Garred, Helle Kristine Skjerven, Ellen Schlichting, Steinar Lundgren, Erik Wist, Bjørn Naume, Vessela N. Kristensen, Anne‐Lise Børresen‐Dale, Ole Christian Lingjærde, Olav Engebraaten	2020	14
9	Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data Cancer Research ·Roohollah Javadi, Oliver Geier, Thomas Fleischer, Øystein Garred, Elin Borgen, Simon W. Funke, Surendra Kumar, Marie E. Rognes, Therese Seierstad, Anne‐Lise Børresen‐Dale, Vessela N. Kristensen, Olav Engebraaten, Alvaro Köhn‐Luque, Arnoldo Frigessi	2019	17
10	DNA methylation patterns in Uveal Melanoma FFPE samples correlate with survival Investigative Ophthalmology & Visual Science ·胡永洁, Wang Jing-fe, Clara‐Cecilie Günther, Leonardo A. Meza‐Zepeda, Øystein Garred, Theresa Kumar, Goran Petrovski, Morten C. Moe, Agate Noer	2018	0
11	Determinants of acquired activated protein C resistance and D-dimer in breast cancer Thrombosis Research ·N S Van-de-Water, Per Morten Sandset, Marie‐Christine Mowinckel, Øystein Garred, Kristine Kleivi Sahlberg, Vessela N. Kristensen, Anne‐Lise Børresen‐Dale, Anne Flem Jacobsen, Grethe Skretting, Nina Iversen	2016	6
12	Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes Cancer & Metabolism ·Tonje H. Haukaas, Leslie R. Euceda, Guro F. Giskeødegård, Santosh Lamichhane, Marit Krohn, Sandra Jernström, Miriam R. R. Aure, Ole Christian Lingjærde, Ellen Schlichting, Øystein Garred, Eldri U. Due, Gordon B. Mills, Kristine Kleivi Sahlberg, Anne‐Lise Børresen‐Dale, Tone F. Bathen	2016	56
13	Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer Lipids in Health and Disease ·Vidar G. Flote, Riyas Vettukattil, Tone F. Bathen, Thore Egeland, Anne McTiernan, Hanne Frydenberg, 范旭红, Yumei Bai, Jon Lømo, Øystein Garred, Ellen Schlichting, Erik A. Wist, Inger Thune	2016	29
14	Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCRgenes are associated with breast cancer: a case-control study BMC Cancer ·N S Van-de-Water, Marte K. Viken, Anders Erik Astrup Dahm, Hans Kristian Moen Vollan, Kristine Kleivi Sahlberg, Øystein Garred, Anne‐Lise Børresen‐Dale, Anne Flem Jacobsen, Vessela N. Kristensen, Ida Bukholm, Rolf Kåresen, Ellen Schlichting, Grethe Skretting, Benedicte A. Lie, Per Morten Sandset, Nina Iversen	2014	34
15	EGFR gene copy number heterogeneity in fine-needle aspiration cytology from breast carcinomas determined by chromogenic in situ hybridization Diagnostic Cytopathology ·Torill Sauer, Kahsai Beraki, Wilkins Kw, Øystein Garred, Oddvar Næss	2005	7
16	Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading Cancer ·Torill Sauer, Jon Lømo, Øystein Garred, Oddvar Næss	2004	11
17	Apical macropinocytosis in polarized MDCK cells: Regulation by N-ethylmaleimide-sensitive proteins European Journal of Cell Biology ·Kirsten Sandvig, Alicia Llorente, Kazunori Hanaoka, Per Eker, Øystein Garred, Martin Stahlhut, Bo van Deurs	2000	12
18	Furin-induced Cleavage and Activation of Shiga Toxin Journal of Biological Chemistry ·Øystein Garred, Bo van Deurs, Kirsten Sandvig	1995	167
19	Entry of Shiga Toxin into Cells Zentralblatt für Bakteriologie ·Kirsten Sandvig, Dubinina Ev, Øystein Garred, Kristian Prydz, Juri V. Kozlov, Steen H. Hansen, Bo van Deurs	1993	9
20	Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum Nature ·Kirsten Sandvig, Øystein Garred, Kristian Prydz, Juri V. Kozlov, Steen H. Hansen, Bo van Deurs	1992	347

About Øystein Garred

Øystein Garred is a scholar working on Cancer Research, Endocrinology, Oncology, Internal Medicine and Cell Biology, having authored 43 papers that have together received 2.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Toxin Mechanisms and Immunotoxins (7 papers), Cellular transport and secretion (7 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Escherichia coli research studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Endocrinology (351 citations), Cell Biology (555 citations), Immunology (469 citations), Biotechnology (148 citations) and Molecular Biology (1.1k citations). Øystein Garred has collaborated with scholars based in Norway, Denmark and United States. Frequent co-authors include Kirsten Sandvig, Bo van Deurs, Grethe Skretting, Frederik Vilhardt, Juri V. Kozlov, Kristian Prydz, Steen H. Hansen, Elin Borgen, Sjur Olsnes and Jon Lømo. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, International Journal of Cancer, Molecular Oncology and Experimental Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact